Everest Organics Reports Mixed Financial Results with Improved Profitability Metrics

Everest Organics, a microcap player in the Pharmaceuticals & Drugs industry, has recently reported its financial results for the quarter ending December 2024. The company has experienced notable developments in its financial metrics, reflecting a positive trajectory in several key areas.
The operating profit to interest ratio has reached its highest point in the last five quarters at 2.87 times, indicating an enhanced capacity to manage interest obligations. Additionally, the operating profit (PBDIT) has also peaked at Rs 4.02 crore, showcasing a favorable trend in profitability. The operating profit margin has improved to 9.56%, suggesting increased efficiency in operations.

Moreover, profit before tax (PBT) and profit after tax (PAT) have both achieved their highest levels in the past five quarters, recorded at Rs 1.15 crore and Rs 1.14 crore, respectively. This reflects a positive trend in the company's profitability metrics. Earnings per share (EPS) have also reached Rs 1.43, indicating a rise in profitability for shareholders.

However, it is important to note that net sales have shown a decline, recorded at Rs 42.05 crore, which is lower than the average of the previous four quarters. This aspect highlights a contrasting trend in sales performance.

Overall, Everest Organics has undergone an adjustment in its evaluation, reflecting the mixed performance across various financial metrics.

Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.